Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
Non-alcoholic fatty liver disease (NAFLD) is a progressive metabolic disease characterized by hepatic steatosis, inflammation, and fibrosis that seriously endangers global public health. Epidemiological studies have shown that the incidence of non-alcoholic fatty liver disease in postmenopausal wome...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Buch |
Veröffentlicht: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Schlagworte: | |
Online-Zugang: | Connect to this object online. |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_2372f2c6aaa64cbe89b5f06816f03f6d | ||
042 | |a dc | ||
100 | 1 | 0 | |a ChenLu Zhao |e author |
700 | 1 | 0 | |a JunHao Shi |e author |
700 | 1 | 0 | |a DongFang Shang |e author |
700 | 1 | 0 | |a Min Guo |e author |
700 | 1 | 0 | |a Cheng Zhou |e author |
700 | 1 | 0 | |a WenXia Zhao |e author |
245 | 0 | 0 | |a Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women |
260 | |b Frontiers Media S.A., |c 2023-08-01T00:00:00Z. | ||
500 | |a 1663-9812 | ||
500 | |a 10.3389/fphar.2023.1237845 | ||
520 | |a Non-alcoholic fatty liver disease (NAFLD) is a progressive metabolic disease characterized by hepatic steatosis, inflammation, and fibrosis that seriously endangers global public health. Epidemiological studies have shown that the incidence of non-alcoholic fatty liver disease in postmenopausal women has significantly increased. Studies have shown that estrogen deficiency is the main reason for this situation, and supplementing estrogen has become a new direction for preventing the occurrence of postmenopausal fatty liver. However, although classical estrogen replacement therapy can reduce the incidence of postmenopausal NAFLD, it has the risk of increasing stroke and cardiovascular diseases, so it is not suitable for the treatment of postmenopausal NAFLD. More and more recent studies have provided evidence that phytoestrogens are a promising method for the treatment of postmenopausal NAFLD. However, the mechanism of phytoestrogens in preventing and treating postmenopausal NAFLD is still unclear. This paper summarizes the clinical and basic research evidence of phytoestrogens and reviews the potential therapeutic effects of phytoestrogens in postmenopausal NAFLD from six angles: enhancing lipid metabolism in liver and adipose tissue, enhancing glucose metabolism, reducing oxidative stress, reducing the inflammatory response, regulating intestinal flora, and blocking liver fibrosis (Graphical Abstract). | ||
546 | |a EN | ||
690 | |a phytoestrogens(PEs) | ||
690 | |a postmenopausal women | ||
690 | |a non-alcoholic fatty liver disease | ||
690 | |a lipid metabolism | ||
690 | |a glucose metabolism | ||
690 | |a oxidative stress | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Pharmacology, Vol 14 (2023) | |
787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2023.1237845/full | |
787 | 0 | |n https://doaj.org/toc/1663-9812 | |
856 | 4 | 1 | |u https://doaj.org/article/2372f2c6aaa64cbe89b5f06816f03f6d |z Connect to this object online. |